Healthpeak Properties, Inc.: Barclays cuts target price to $21 from $24
DOC•Barclays cut its target price for Healthpeak Properties to $21 from $24.
Related News
Spire Global raised to buy from neutral by Alliance Global Partners
SPIR•
Kimberly-Clark receives requisite consents for amendments to all Kenvue notes
KMB•
Empire Petroleum director Phil E. Mulacek reports $68,978 common share purchase
EP•
Horizon Space Acquisition I agrees to merge with ArcheNova Biotech in deal targeting Nasdaq listing
HSPO•
OMA taps EY as external auditor for fiscal 2026, replacing Deloitte
OMAB•